Brazil has quote "serious" defects and "inherent" risks of the vaccine ... Apr 27
Top ten Indian small cap pharma stocks Jan 2021... Jan 08
The positive assessment from ANVISA reaffirms WuXi Biologics' strong commitment to offering partners a global manufacturing network of the highest standard... Dec 28
Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%... Dec 21
Brazilian health regulator Anvisa has said that Chinese health authorities had not been transparent in approving its COVID-19 vaccine ‘CoronaVac’ for emergency use. ... Dec 17
PDS Biotech and Farmacore today announced Updates on its co-development program for a Versamune®-based vaccine aimed at preventing COVID-19 infection.... Nov 11
The regulator says testing of the vaccine would continue after the death and provides no further details. ... Oct 22
... Oct 17
US FDA approved for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery... Oct 05
Brazil’s health regulator Anvisa on Tuesday authorized AstraZeneca PLC to test its COVID-19 vaccine on an additional 5,000 volunteers in the country ... Sep 17
Brazil goes ahead with Johnson and Johnson's COVID-19 vaccine ... Aug 21
Gufic Lifesciences has entered into a loan agreement with Hetero Labs Limited to manufacture and supply Remdesivir lyophilised powder ... Aug 12
Aurobindo Pharma Hyderabad is ready for impressive growth, riding on vaccines and Biosimilars for Covid-19... Aug 10
The Proposed Combination relates to acquisition of less than 5% shareholding ofIntas Pharmaceuticals Limited (Intas) by Canary Investments Limited (Canary) and Link Investment Trust II (... May 01
Centaur Pharmaceuticals’ state-of-the-art API Ambernath facility was audited by the USFDA and a 483 form was issued with one observation... Nov 27
Centaur Pharma’s API Ambernath facility receives EIR from USFDA... Nov 16
LifeSan Clinical Research, the clinical research division of Centaur Pharmaceuticals was audited by the US FDA and was concluded with zero 483 observations which signifies ... Sep 11
Samsung Bioepis’ BRENZYS™ (etanercept) becomes available in Brazil through Brazil’s public health system, Sistema Único de Saúde (SUS) Established seven years ago, Samsung ... Sep 11
-Advertisements-
Saturday, June 01, 2024
.jpg)
